Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jia Huang, Yun Wang, Jun Chen, Yanlei Zhang, Zheng Yuan, Li Yue, Josep Maria Haro, Maria Victoria Moneta, Diego Novick & Yiru Fang. (2018) Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline. Neuropsychiatric Disease and Treatment 14, pages 2473-2484.
Read now
Read now
Diego Novick, William Montgomery, Ellen Vorstenbosch, Maria Victoria Moneta, Héctor Dueñas & Josep Maria Haro. (2017) Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study. Patient Preference and Adherence 11, pages 1859-1868.
Read now
Read now
Diego Novick, William Montgomery, Josep Maria Haro, Maria Victoria Moneta, Gang Zhu, Li Yue, Jihyung Hong, Héctor Dueñas & Roberto Brugnoli. (2016) Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia. Neuropsychiatric Disease and Treatment 12, pages 383-392.
Read now
Read now
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015) Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting. Patient Preference and Adherence 9, pages 1481-1490.
Read now
Read now
Diego Novick, Jihyung Hong, William Montgomery, Héctor Dueñas, Magdy Gado & Josep Maria Haro. (2015) Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatric Disease and Treatment 11, pages 197-205.
Read now
Read now
Héctor Dueñas, Alan J. M. Brnabic, Arier Lee, Angel L. Montejo, Siva Prakash, MA. Luz S. Casimiro-Querubin, Mohamed Khaled, Martin Dossenbach & Joel Raskin. (2011) Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period. International Journal of Psychiatry in Clinical Practice 15:4, pages 242-254.
Read now
Read now
Articles from other publishers (15)
Caroline W Espinola, Yuelee Khoo, Roohie Parmar, Ilya Demchenko, Benicio N Frey, Roumen V Milev, Arun V Ravindran, Sagar V Parikh, Keith Ho, Susan Rotzinger, Wendy Lou, Raymond W Lam, Sidney H Kennedy & Venkat Bhat. (2022) Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report. Journal of Psychopharmacology 36:5, pages 604-613.
Crossref
Crossref
James Brockbank, Taryn Krause, Emily Moss, Anne Milthers Pedersen, Michael Frank Mørup, Outi Ahdesmäki, Jake Vaughan & Thor-Henrik Brodtkorb. (2021) Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Paula L. Jacobsen, George G. Nomikos, Wei Zhong, Andrew J. Cutler, John Affinito & Anita Clayton. (2019) Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. CNS Spectrums 25:1, pages 50-63.
Crossref
Crossref
Joanna Sniecikowska, Adrian Newman-Tancredi & Marcin Kolaczkowski. (2019) From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery. Current Topics in Medicinal Chemistry 19:26, pages 2393-2420.
Crossref
Crossref
Angel Montejo, Nieves Prieto, Rubén de Alarcón, Nerea Casado-Espada, Javier de la Iglesia & Laura Montejo. (2019) Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach. Journal of Clinical Medicine 8:10, pages 1640.
Crossref
Crossref
Angel L. Montejo, Joemir Becker, Gloria Bueno, Raquel Fernández-Ovejero, María T. Gallego, Nerea González, Adrián Juanes, Laura Montejo, Antonio Pérez-Urdániz, Nieves Prieto & José L. Villegas. (2019) Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study. Journal of Clinical Medicine 8:5, pages 719.
Crossref
Crossref
Angel L. Montejo, Julia Calama, Fernando Rico-Villademoros, Laura Montejo, Nerea González-García & Jesús Pérez. (2019) A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study. Archives of Sexual Behavior 48:3, pages 923-933.
Crossref
Crossref
Pratap R. Chokka & Jeffrey R. Hankey. (2017) Assessment and management of sexual dysfunction in the context of depression. Therapeutic Advances in Psychopharmacology 8:1, pages 13-23.
Crossref
Crossref
Jihyung Hong, Diego Novick, Maria Victoria Moneta, Ahmed El-Shafei, Héctor Dueñas & Josep Maria Haro. (2017) Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East. Clinical Practice & Epidemiology in Mental Health 13:1, pages 145-155.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015)
Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in
E
ast
A
sia
. Asia-Pacific Psychiatry 8:1, pages 51-59.
Crossref
Crossref
David V. Sheehan, Michele Mancini, Jianing Wang, Lovisa Berggren, Haijun Cao, Héctor José Dueñas & Li Yue. (2015) Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental 31:1, pages 53-63.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Jaume Aguado, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015) Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?. Clinical Practice & Epidemiology in Mental Health 11:1, pages 130-139.
Crossref
Crossref
Syed MohiuddinKatherine Payne. (2014) Utility Values for Adults with Unipolar Depression. Medical Decision Making 34:5, pages 666-685.
Crossref
Crossref
David S. Baldwin, M. Carlotta Palazzo & Vasilios G. Masdrakis. (2013) Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants. Depression Research and Treatment 2013, pages 1-8.
Crossref
Crossref
A. Brnabic, J. Raskin, L. Alev, E. Serap Monkul & A. Lowry. (2012) Frequency and outcomes of painful physical symptoms in a naturalistic population with major depressive disorder: an analysis of pooled observational studies focusing on subjects aged 65 years and over. International Journal of Clinical Practice 66:12, pages 1158-1167.
Crossref
Crossref